Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II
The focus of the study is to test a nurse-led telephone-based palliative care intervention on improving the delivery of care for patients with newly diagnosed lung cancer. The study is a three site randomized control trial to determine the efficacy of the intervention on improving patients' quality of life, symptom burden, and satisfaction of care. Additionally, the study will test an innovative care delivery model to improve patients' access to palliative care. The investigators will also determine the effect of the intervention on patient activation to discuss treatment preferences with their clinician and on clinician knowledge of patients' goals of care.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Jul 27, 2023 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Treatment
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- VA Office of Research and Development
- Interventions being studied
- Behavioral: Palliative Care
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
- Patients diagnosed at the Puget Sound Health Care System, Birmingham VA, or Portland VA with a primary diagnosis of lung cancer that requires more than surgical resection:
- diagnosed within 8 weeks of recruitment
- must have telephone access
- ability to understand English
- able to participate in informed consent process
- Patients not eligible to participate in the study include those who are inpatients prior to randomization,
- those who are under the care of palliative care or hospice at the time of randomization
- those who have severe mental health disorders
- those who are unable to speak directly with the nurse over the telephone
- or those that have the inability to provide informed consent
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Birmingham VA Medical Center, Birmingham, ALBirmingham, Alabama
- VA Portland Health Care System, Portland, ORPortland, Oregon
- VA Puget Sound Health Care System Seattle Division, Seattle, WASeattle, Washington
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 27, 2023. Always confirm current availability with the study team.